News
-
Quotient Announces The First Use Of ivMicrotracer To Support A Regulatory Drug Approval Submission
9/7/2011
Quotient Clinical, a business unit of Quotient Bioresearch (Quotient), recently announced that absolute bioavailability data from an ivMicrotracer study has been used to support a submission for regulatory drug approval.
-
NEW Aerosol Exposure Unit For Mice & Rats
9/2/2011
This system is ideally suited for exposing groups of mice or rats to aerosolized powders or liquids. This is Harvard Apparatus-Hugo Sachs Electronik's first system dedicated to inhalation studies in awake animal models.
-
Absorption Systems Boosts Ophthalmic Drug Testing
8/24/2011
Absorption Systems recently announced that, as part of the continuing expansion of capabilities at its San Diego, CA facility, the company has hired Glen Gum, M.S., Ph.D. as Associate Director of Preclinical Studies.
-
Cytokinetics Announces Phase I And Phase IIa Clinical Trial Results For Omecamtiv Mecarbil Published In The Journal Lancet
8/23/2011
Cytokinetics, Incorporated (NASDAQ: CYTK) announced today the publication of results from two clinical trials of omecamtiv mecarbil, a novel cardiac myosin activator, in the August 20, 2011 issue of the journal Lancet.
-
GE Healthcare Launches Indicating FTA DMPK Cards For Colorless Biological Sample Bioanalysis
8/16/2011
GE Healthcare Life Sciences new Whatman Indicating FTA DMPK Cards enable simple and effective collection of colorless biosample fluids, such as plasma, urine and CSF, for use in pharmacokinetic and toxicokinetic studies.
-
Scientists Design Nano-Sized Drug Transporter To Fight Disease
7/29/2011
Scientists seeking to improve cancer treatments have created a tiny drug transporter that maximizes its ability to silence damaging genes by finding the equivalent of an expressway into a target cell.
This website uses cookies to ensure you get the best experience on our website. Learn more